Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AvePoint (AVPT) Cash & Equivalents (2019 - 2025)

AvePoint (AVPT) has disclosed Cash & Equivalents for 7 consecutive years, with $481.1 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 65.46% to $481.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $481.1 million through Dec 2025, up 65.46% year-over-year, with the annual reading at $481.1 million for FY2025, 65.46% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $481.1 million at AvePoint, up from $471.6 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $481.1 million in Q4 2025, with the low at $139492.0 in Q1 2021.
  • Average Cash & Equivalents over 5 years is $235.6 million, with a median of $227.1 million recorded in 2022.
  • The sharpest move saw Cash & Equivalents crashed 81.66% in 2021, then surged 56364.89% in 2022.
  • Over 5 years, Cash & Equivalents stood at $268.2 million in 2021, then dropped by 15.3% to $227.2 million in 2022, then decreased by 1.77% to $223.2 million in 2023, then soared by 30.28% to $290.7 million in 2024, then surged by 65.46% to $481.1 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $481.1 million, $471.6 million, and $429.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.